RankingsPricing
  1. US-listed companies
  2. ACADIA PHARMACEUTICALS INC
  3. Financials
  4. Total cash & short-term investments

ACADIA PHARMACEUTICALS INCACAD

Market cap
$3.9B
P/E ratio
SummaryFinancials
Period EndTotal cash & short-term investments (Million USD)YoY (%)
Dec 31, 2024756+72.26%
Dec 31, 2023439+5.29%
Dec 31, 2022417-19.95%
Dec 31, 2021521-17.60%
Dec 31, 2020632-9.39%
Dec 31, 2019697+47.29%
Dec 31, 2018474+38.72%
Dec 31, 2017341-35.48%
Dec 31, 2016529+145.91%
Dec 31, 2015215-33.29%
Dec 31, 2014322+73.58%
Dec 31, 2013186+17.56%
Dec 31, 2012158+186.26%
Dec 31, 201155

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)